SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Sernova Biotherapeutics Announces Warrant Amendments
February 20, 2026
 · 
3 min read
Press Releases
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position for Theralase(R) in the past.
February 20, 2026
 · 
8 min read
Press Releases
From AI-driven drug discovery to the era of “cell debugging.” - Commentary by Unexakorea
February 20, 2026
 · 
1 min read
Press Releases
Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation
February 20, 2026
 · 
1 min read
Press Releases
MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury
February 20, 2026
 · 
3 min read
Press Releases
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
February 20, 2026
 · 
1 min read
Press Releases
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
February 20, 2026
 · 
1 min read
Press Releases
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
February 20, 2026
 · 
10 min read
Press Releases
enGene to Participate in Upcoming Investor Conferences - February 20, 2026
February 20, 2026
 · 
1 min read
Press Releases
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
February 20, 2026
 · 
1 min read
Press Releases
CORRECTION FROM SOURCE: The Nomination Committee’s Proposal for New Board Members
February 20, 2026
 · 
2 min read
Press Releases
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
February 20, 2026
 · 
6 min read
Press Releases
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
February 20, 2026
 · 
4 min read
Press Releases
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
February 20, 2026
 · 
4 min read
Press Releases
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
February 20, 2026
 · 
4 min read
Press Releases
Annual General Meeting in ALK-Abelló A/S on 16 March 2026
February 20, 2026
 · 
1 min read
Press Releases
Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
February 20, 2026
 · 
10 min read
Press Releases
The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors
February 20, 2026
 · 
2 min read
Press Releases
ABLi Therapeutics Announces Publication of the Final Results from the Phase 2 ‘201 Trial’ Evaluating Risvodetinib for the Treatment of Parkinson’s Disease
February 20, 2026
 · 
3 min read
Press Releases
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
February 20, 2026
 · 
5 min read
Press Releases
AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board
February 20, 2026
 · 
7 min read
Press Releases
Nasus Pharma to Participate in Upcoming Investor Conferences - February 20, 2026
February 20, 2026
 · 
1 min read
Press Releases
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
February 20, 2026
 · 
5 min read
Press Releases
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
 · 
5 min read
Press Releases
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
February 5, 2026
 · 
4 min read
Press Releases
Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging
February 5, 2026
 · 
7 min read
Press Releases
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 5, 2026
 · 
1 min read
Press Releases
Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
February 5, 2026
 · 
1 min read
Press Releases
Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™
February 5, 2026
 · 
7 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
 · 
1 min read
Press Releases
Primmune Therapeutics Appoints Chief Medical Officer and Executive Board Chair; Establishes Melanoma Clinical Study Advisory Board
February 5, 2026
 · 
5 min read
Press Releases
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026
February 5, 2026
 · 
1 min read
Press Releases
Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at Scripps’ Structural Heart Intervention and Imaging 2026 Conference
February 5, 2026
 · 
2 min read
Press Releases
Apogee Therapeutics to Participate at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 5, 2026
 · 
1 min read
Load More